Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Job Requisition ID # 26WD99999 Position Overview We are looking for an enthusiastic and motivated finance business partner to join the Global Enterprise Account Finance team within Sales Finance. You will support the assigned sales teams